Evidence-Based Complementary and Alternative Medicine

Volume 2014 (2014), Article ID 542825, 12 pages

http://dx.doi.org/10.1155/2014/542825

Research Article

U-Bang-Haequi Tang: A Herbal Prescription that Prevents Acute Inflammation through Inhibition of NF-B-Mediated Inducible Nitric Oxide Synthase

Min Hwangbo,¹ Ji Yun Jung,² Sung Hwan Ki,³ Sang Mi Park,² Kyung Hwan Jegal,² Il Je Cho,² Ju-Hee Lee,² Seung Ho Kang,⁴ Sun-Dong Park,⁵ Sae Kwang Ku,² Sang Chan Kim,² Rong Jie Zhao,2,6 Seon Young Jee,¹ and Young Woo Kim2,5

¹Department of Ophthalmology, Otolaryngology & Dermatology, Daegu Haany University, Daegu 706-828, Republic of Korea

²Medical Research Center for Globalization of Herbal Formulation, College of Oriental Medicine, Daegu Haany University, Daegu 706-828, Republic of Korea

³College of Pharmacy, Chosun University, Gwangju 501-759, Republic of Korea

⁴Sunlin University, Pohang 791-712, Republic of Korea

⁵College of Oriental Medicine, Dongguk University, Gyeongju 780-714, Republic of Korea

⁶Department of Pharmacology, Mudanjiang Medical University, Mudanjiang 157011, China

Received 18 February 2014; Revised 16 April 2014; Accepted 18 April 2014; Published 15 May 2014

Academic Editor: Bor-Show Tzang

Copyright © 2014 Min Hwangbo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Since antiquity, medical herbs have been prescribed for both treatment and preventative purposes. Herbal formulas are used to reduce toxicity as well as increase efficacy in traditional Korean medicine. U-bang-haequi tang (UBT) is a herbal prescription containing Arctii fructus and Forsythia suspensa as its main components and has treated many human diseases in traditional Korean medicine. This research investigated the effects of UBT against an acute phase of inflammation. For this, we measured induction of nitric oxide (NO) and related proteins in macrophage cell line stimulated by lipopolysaccharide (LPS). Further, paw swelling was measured in carrageenan-treated rats. Carrageenan significantly induced activation of inflammatory cells and increases in paw volume, whereas oral administration of 0.3 or 1 g/kg/day of UBT inhibited the acute inflammatory response. In RAW264.7 cells, UBT inhibited mRNA and protein expression levels of iNOS. UBT treatment also blocked elevation of NO production, nuclear translocation of NF-B, phosphorylation of I-B induced by LPS. Moreover, UBT treatment significantly blocked the phosphorylation of p38 and c-Jun NH2-terminal kinases by LPS. In conclusion, UBT prevented both acute inflammation in rats as well as LPS-induced NO and iNOS gene expression through inhibition of NF-B in RAW264.7 cells.

1. Introduction

Inflammation is a crucial and physiological response of the immune system to infection [1–3]. This complex biological symptom is often caused by invading pathogens during harmful injury of human tissues [1–3]. In the inflammatory processes, an acute phase of inflammation is the initial responses, which include the increased movement of plasma and inflammatory cells from the blood stream to the tissue [1–3]. It has been shown that inflammation is related to the pathogenesis of various disorders such as metabolic disease, pulmonary disease, neoplasm, and infection [1–5]. Inflammatory reactions are mediated by signaling pathway in macrophage and mast cells and regulated by many factors (e.g., proinflammatory enzymes, cytokines, and other mediators) [6–9].

Lipopolysaccharide (LPS) is gram-negative bacteria and can activate macrophages as indicated by production of nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukins (ILs), and leukotrienes [10]. In fact, NO is a key mediator in the immunological defense and vasodilation. However, a large amount of NO can induce oxidative damage and nitrogen stress [11]. NO induced from L-arginine by NO synthase (NOS) enzymes in activated immune cells such as macrophages. NOSs are classified to three forms, that is, endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS). Among them, iNOS produces high concentration of NO in specific tissue and mediates some autoimmune diseases such as chronic inflammation and sepsis [12].

TNF-α is known to play an important role as a macrophage activator and an initiator of immune response [13]. IL-6 is another crucial inflammatory cytokine and produced by macrophage cells [13]. It is also known to have a role in the acute phase of inflammation [13]. Nuclear factor-kappa B (NF-κB) has been studied that it has proinflammatory activity by controlling inflammatory gene expressions [14]. In inactivated state, NF-κB exists in cells as homodimeric or heterodimeric complexes and remains in the cytoplasm of cells by association with the NF-κB inhibitory protein and inhibitory kappa B (I-κB) [14]. However, once released from I-κBα in the cytosol, NF-κB can translocate into nuclei to activate the expression of proinflammatory genes such as iNOS, TNF-α, and IL-6 [15]. Prostaglandin E₂ (PGE₂) is also significant mediator which is produced from arachidonic acid metabolites [16].

U-bang-haequi tang (UBT) (Niu Bang Jie Ji Tang in Chinese) is a herbal prescription consisting of Arctii fructus and Forsythia suspensa as main components. In traditional Korean medicine, this herbal formula has been used for long period to treat a variety of diseases such as fever, infection, and inflammatory disorders. It is comprised mostly of cool plants that can remove pathogens from the body surface and alleviate swelling. To verify inhibitory effects of UBT on acute inflammation, we used the carrageenan-induced paw swelling animal model and activated macrophage cell model by LPS. In this study, we confirmed the effects of UBT against acute phase of inflammation in association with the inhibition of NF-κB-mediated NO and PGE₂ production.

2. Materials and Methods

2.1. Preparation of the UBT

The herbal components of UBT were purchased from Daewon pharmacy (Daegu, Korea) (Table 1). UBT was prepared by boiling 210 g of UBT in 1 L of water for 3 h and filtered by a 0.2 μm filter (Nalgene, New York, NY, USA). It was lyophilized and stored at −20°C until use. The amount of UBT was estimated by the dried weight, and the yield was 18.75%.

Table 1: Herbal components in U-bang-haequi tang UBT.

Name of medical herbs
Contents in the prescription g

Fructus  Arctii
10

Fructus  Forsythiae
12

Herba  Dendrobii
12

Herba  Menthae
10

Fructus  Gardeniae
10

Radix  Scrophulariae
10

Herba  Schizonepetae
6

Cortex  Moutan  Radicis
10

Spica  Prunellae
12

Total
92

2.2. Materials

Anti-I-κBα, anti-p-I-κBα, anti-iNOS, horseradish peroxidase-conjugated anti-mouse, anti-goat IgGs, and antibody for phosphorylation of mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinase (ERK), c-Jun NH₂-terminal kinase (JNK), and p38 were purchased from Cell Signaling (Beverely, MA, USA). Anti-anti-NF-κB p65, HSP 70 and Lamin A/C antibodies were supplied from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-murine iNOS was purchased from BD Bioscience (San Jose, CA, USA). PGE₂ assay kit was supplied from R&D system (Minneapolis, MN, USA). TNF-α and IL-6 were supplied from Thermo Scientific (Waltham, MA, USA). Polyethylene glycol number 400 (PEG) solution, carrageenan, dexamethasone, and other reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA).

2.3. Carrageenan-Induced Paw Edema

Animal experiments were conducted under the guidelines of the Institutional Animal Care and Use Committee at Daegu Haany University (DHU). Sprague-Dawley rats at 4 weeks of age (male, 80–100 g) were provided from Hyochang Sience (Daegu, Korea) [17]. Rats () were divided into five groups, and thus each group is five animals. UBT, dissolved in 40% of PEG number 400, was given to rats at the dose of 0.3 or 1 g/kg/day (p.o.) for 4 days. Dexamethasone (1 mg/kg/day) is a known anti-inflammatory drug and we used it as a positive control [18]. The paw volumes were measured up to 3 h after the carrageenan injection at intervals of 1 h. The hind paw volume was verified volumetrically by measuring using a plethysmometer (UGO BASILE, VA, Italy). After euthanasia, the paw samples were prepared.

2.4. Histological Process

The hind paw dorsum and ventrum pedis skins were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned (3~4 μm), and stained with hematoxylin and eosin (H&E) [19]. The histopathological analysis of tissue samples was assessed under light microscope (Nikon, Japan).

2.5. Toluidine Blue Staining

The paw histological paraffin sections were deparaffinized. And then, they were stained with toluidine blue working solution for 2-3 minutes (1% toluidine blue contains 1% sodium chloride pH 2.2~2.5) and then dehydrated and mounted.

2.6. Histomorphometry

The thicknesses of dorsum and ventrum pedis skins (from epidermis to dermis; keratin layers were excluded) were measured using automated image analyzer (DMI-300 Image Processing; DMI, Korea) under magnification 40 of microscopy (Nikon, Japan) at prepare skin histological samples as mm/paw. The infiltrated inflammatory cells were also counted using automated image analyzer as cells/mm² of dermis under magnification 200 of microscopy [19].

2.7. Cell Culture

Raw264.7 cell, a murine macrophage cell line, and THP-1 cells, a human monocytic cell line, were obtained from American Type Culture Collection (Rockville, MD, USA). Raw264.7 cells were incubated with 1 μg/mL LPS (Escherichia coli 026:B6; Sigma, St. Louis, MO, USA). The cells were incubated without 10% fetal bovine serum for 24 h and then stimulated to LPS or LPS + UBT for the indicated time periods. UBT dissolved in distilled water was treated in medium 1 h before the addition of LPS.

2.8. MTT Cell Viability Assay

The cells were plated at a density of 1 × 10⁵ cells per well in a 24-well plate to determine any potential cytotoxicity [17]. Cells were treated with UBT for the 18 h. After incubation of the cells, live cells were stained with MTT (0.5 μg/mL, 4 h). Produced formazan crystals were dissolved by 300 μL dimethyl sulfoxide. Absorbance was measured at 540 nm using a Titertek Multiskan Automatic microplate reader (model MCC/340, Huntsville, AL, USA).

2.9. Assay of Nitrite Production

Raw264.7 cells were treated with UBT at the indicated doses for 1 h and continuously incubated with LPS (1 μg/mL) for the next 18 h. NO production was monitored by measuring the nitrite content [17]. This was performed by mixing the culture medium with Griess reagent (1% sulfanilamide, 0.1% N-1-naphthylenediamine dihydrochloride and 2.5% phosphoric acid). The sample and reagent mixture were incubated in room temperature for 10 minutes. And then, the absorbance was assessed at 540 nm after 10 min.

2.10. Enzyme-Linked Immunosorbent Assay (ELISA)

To measure the TNF-, IL-6 and PGE₂ contents, Raw264.7 cells were incubated with UBT for 1 h and continuously stimulated with LPS for 12 h according to the manufacturer’s instruction [16].

2.11. Immunoblot Analysis

Cells were lysed in the RIPA buffer [17]. Cell lysates were centrifuged at 15,000 g for 10 min to remove debris. The immunoreactive bands were visualized using enhanced chemiluminescence (ECL) detection kit (Amersham Biosciences Corp., Piscataway, NJ, USA) according to the manufacturer’s instructions. Equal loading of proteins was verified by actin or Lamin immunoblottings. Nuclear extracts were prepared as previously described [18]. Intensity of the bands was determined using an image analyzing system (Ultra-Vilolet Products Lts., Upland, CA, USA). Repeated experiments were separately performed to confirm changes.

2.12. Real-Time RT-PCR Analysis

Total RNA was isolated from RAW264.7 using Trizol reagent (Invitrogen, Carlsbad, CA, USA). Real-time PCR was carried out according to the manufacturer’s instructions [18]. We used a light cycler DNA master SYBR green-I kit (Light-Cycler 2.0, Roche, Mannheim, Germany). The relative levels of iNOS (sense: 5′-CCTCCTCCACCCTACCAAGT-3′, antisense: 5′-CACCCAAAGTGCTTCAGTCA-3′, 199 bp) were normalized based on the level of glyceraldehyde-3-phosphate dehydrogenase (sense: 5′-AACGACCCCTTCATTGAC-3′, antisense: 5′-TCCACGACATACTCAGCAC-3′, 173 bp).

2.13. Statistical Analysis

One-way analysis of variance (ANOVA) was used to analyze statistical significance of differences among each group. For assessing statistically significant effect, the Newman-Keuls test was used for comparisons between multiple group means. The data were expressed as means confidence intervals.

3. Results

3.1. Effect of UBT on Volume Changes in Carrageenan-Induced Paw Edema

First, we showed the anti-inflammatory effect of UBT in the paw edema animal model. This carrageenan-induced paw swelling model is well known for screening the efficacy of drug candidates [20]. In this study, carrageenan injection successfully induced an increase of paw volume from 1 h. And this persisted up to 3 h after the injection (Figure 1). Oral administration of UBT 0.3 and 1 g/kg/day for 4 days inhibited the effect of carrageenan to induce paw swelling. We also compared positive control drug, dexamethasone (1 mg/kg/day, p.o., for 4 days), which also decreased the edema formation.

Figure 1: Inhibition of carrageenan-induced paw swelling by UBT. The UBT was administered to rats at the oral dose of 0.3 or 1.0 g/kg/day. The swelling volume of the paw was measured at 1–3 h after carrageenan injection. Dexamethasone (Dex, 1 mg/kg, p.o.) was used as a positive control. Data represents the mean ± S.E.M. of five animals (significant as compared with control, ; significant as compared with carrageenan alone, , ). For data points where error bars could not be seen, the standard error was subtended by the data point. UBT, U-bang-haequi tang.

3.2. Effect of UBT in Carrageenan-Induced Acute Inflammation

We assessed histological analysis of rat skin in ventrum and dorsum pedis by staining with H&E. As expected, carrageenan induced paw swelling in ventrum and dorsum pedis (Figures 2 and 3). Increase of the ventrum and dorsum pedis thicknesses was detected as results of acute edematous inflammation in carrageenan treated rats as compared with vehicle paw skins (Table 2). Carrageenan also induced increase of infiltrated inflammatory and degranulation-related decreases of mast cell, which are widely distributed through body and play a key role in inflammation (Table 2). Treatment of UBT (1.0 g/kg/day) significantly inhibited the mast cell degranulation and restored the number of mast cells as well as decreased the infiltration of inflammatory cells. All of these results suggest that UBT may have an anti-inflammatory effect in rats.

Table 2: Changes on the histomorphometrical analysis of hind paw skins group summary.

Groups
Skins index

Dorsum pedis skin
Ventrum pedis skin

Total thickness m
IF cell numbers cells/mm²
Mast cell numbers cells/mm²
Total thickness m
IF cell numbers cells/mm²
Mast cell numbers cells/mm²

Control

    Intact

    CA

Reference

    Dexamethasone

Test material (g/kg)

    UBT 0.3

    UBT 1.0

Values are expressed as mean ± SD of five rat hind paws.

CA: carrageenan.

IF: infiltrated inflammatory cells.

as compared with intact control by LSD test.

and c as compared with CA control by LSD test.

as compared with intact control by MW test.

and f as compared with CA control by MW test.

Figure 2: Histological profile of the dorsum pedis skin, taken from vehicle control (a), carrageenan control (b), dexamethasone (c), carrageenan + UBT 0.3 (d), and UBT 1.0 g/kg (e) treated rats. Histomorphometry of the dorsum pedis skin stained with H&E. Arrow indicates total thicknesses measured. Scale bars = 80 μm. CA, carrageenan; ED, epidermis; DM, dermis; HD, hypodermis; PM, paw muscle.

Figure 3: Histological profile of the ventrum pedis skin, taken from vehicle control (a), carrageenan control (b), dexamethasone (c), carrageenan + UBT 0.3 (d), and UBT 1.0 g/kg (e) treated rats. Histomorphometry of the ventrum pedis skin stained with H&E and used for histological samples. Arrow means total thicknesses. Scale bars = 80 μm. CA, carrageenan; ED, epidermis; DM, dermis; HD, hypodermis; PM, paw muscle.

3.3. Inhibition of LPS-Inducible NO, PGE₂ and Pro-Inflammatory Cytokines Production

In the next step, this study extended to effects of UBT on inflammation in vitro. We evaluated cellular toxicity of UBT in Raw264.7 cells. In MTT assay, cell survival was not affected by UBT treatment 0.5 and 1.0 mg/mL (i.e., control, %; UBT 0.5 mg/mL, %; UBT 1.0 mg/mL %). Next, we determined the effect of UBT on NO production in LPS-induced Raw264.7 cells. As expected, LPS (1 μg/mL, 18 h) increased NO accumulation, which was significantly reduced by UBT (0.2, 0.5 and 1.0 mg/mL) in a concentration-dependent manner (Figure 4(a)). LPS-stimulated PGE₂ production in Raw264.7 cells was also blocked by UBT (0.5 and 1.0 mg/mL) (Figure 4(b)).

(a)

(b)

(c)

(d)

Figure 4: Inhibition of LPS-inducible NO and PGE₂ by UBT. (a) NO and (b) PGE₂ accumulations. Raw264.7 cells were treated with 0.2, 0.5, and 1.0 mg/mL of UBT for 1 h, and continuously with LPS (1 μg/mL) for the next 18 h. (c) TNF-α and IL-6 contents in culture medium. Raw264.7 cells were stimulated by LPS with or without 1.0 mg/mL UBT for 12 h. (d) TNF-α and IL-6 mRNA levels. THP-1 cells were stimulated by LPS with or without 1.0 mg/mL UBT for 12 h. Data represents the mean ± S.E.M. from four separate experiments (significant as compared with control, ; significant as compared with LPS alone, , ). UBT, U-bang-haequi tang.

To confirm the effect of UBT on cytokines, we measured TNF-α and IL-6 production in Raw264.7 cells by using ELISA assay. LPS-inducible increased the productions of TNF-α and IL-6 in culture media of Raw264.7 cells (Figure 4(c)). Treatment of UBT (1.0 mg/mL) decreased the ability of LPS (1 μg/mL, 12 h) to increase the cytokines accumulation (Figure 4(c)). Moreover, we additionally determined the effects of UBT on TNF-α and IL-6 in THP-1 cells. UBT pretreatments completely inhibited increase in the relative mRNA expression of TNF-α and IL-6 elicited by LPS (Figure 4(d)).

3.4. Effect of UBT on the LPS-Induced iNOS Gene Expression

Next, we assessed immunoblot analysis to verify the protein expressions of iNOS. Raw264.7 cells were pretreated with UBT (0.5 and 1.0 mg/mL) for 1 h and LPS treatment at 1 μg/mL for 18 h dramatically increased protein levels of iNOS (Figure 5(a)). Densitometer analysis revealed that UBT treatment significantly inhibited the iNOS protein expressions in Raw264.7 cells (Figure 5(a)). Moreover, real-time RT-PCR analysis verified the effect of UBT on iNOS mRNA expression. UBT significantly repressed the increase of its mRNA by LPS, which implies that UBT can downregulate the gene induction of iNOS (Figure 5(b)).

(a)

(b)

Figure 5: Inhibition of LPS-inducible iNOS gene expression by UBT. (a) Representative iNOS immunoblottings. (b) Relative iNOS mRNA levels. The expressions of protein and mRNA were assessed 18 h after treatment with LPS + UBT. Data represents the mean ± S.E.M. from three experiments (significant as compared with control, ; significant as compared with LPS alone, , ). UBT, U-bang-haequi tang.

3.5. Effect of UBT on LPS-Inducible Degradation of I-κBα and Phosphorylation of MAPKs

NF-κB serves as the important transcription factor for the induction of the proinflammatory genes in microphage cells stimulated by inflammatory inducers such as LPS [20–22]. NF-κB translocates to the nucleus by phosphorylation of I-κBα (p-I-κBα) and subsequent degradation of I-κBα subunit. Exposure of LPS decreased the protein level of p-I-κBα and I-κBα at 30 min. Treatment of Raw264.7 cells with UBT for 1 h inhibited the phosphorylation and degradation of I-κBα induced by LPS (Figure 6(a)). Moreover, UBT also blocked the translocation of nuclear NF-κB by LPS treatment (Figure 6(b)). These results suggest that UBT might prevent translocation of NF-κB to the nucleus by phosphorylation and degradation of I-κBα.

(a)

(b)

(c)

Figure 6: Effect of UBT on LPS-inducible degradation of I-κBα and phosphorylation of mitogen-activated protein kinases (MAPKs). (a) The level of I-κBα and p-I-κBα in total lysates. Raw264.7 cells were stimulated with LPS or LPS + UBT for 30 min. Immunoblots are representative of results from repeated experiments. (b) Nuclear and cytosolic level of NF-κB. Lamin A/C and HSP 70 confirmed equal loading and purity of the each fraction. (c) The phosphorylation c-Jun NH₂-terminal kinase (JNK), p38, and extracellular signal-regulated kinase (ERK) in total lysates. Raw264.7 cells were incubated with LPS UBT for 30 min. For A and C, data represents the mean ± S.E.M. from three separate experiments (significant as compared with control, ; significant as compared with LPS alone, ). JNK, c-Jun NH₂-terminal kinase; ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; UBT, U-bang-haequi tang.

MAPKs, the serine/threonine protein kinases, consisted of three family members (i.e., JNK, p38, and ERK) and play key roles in regulation of the inflammatory responses by leading to activation of NF-κB and induction of proinflammatory genes [23]. To investigate the upstream molecular target of UBT, we assessed the effects of UBT on LPS-induced phosphorylation of JNK, p38, and ERK. As expected, treatment of LPS upregulated phosphorylation of JNK, p38, and ERK. However, cotreatment of UBT resulted in significantly decreased phosphorylation of JNK and p38, but not ERK (Figure 6(c)).

4. Discussion

A medical herb has been mixed with other herbs, which is called a herbal prescription, and this mixture of various medical herbs is necessary for reducing toxicity and potentiating efficacy in traditional medicine [24]. UBT prescription is composed of 9 medical herbs including of Fructus Arctii, Herba Menthae, Fructus Gardeniae, Herba Dendrobii, Herba Schizonepetae, Fructus Forsythiae, Radix Scrophulariae, Cortex Moutan Radicis, and Spica Prunellae (Table 1). In traditional Eastern medicine, this prescription comprises cool ingredients that can treat pathogens from the body surface and alleviate phlegm and has been used to treat a variety of diseases such as early-stage infections in head and neck regions with obvious redness, swelling, heat, and pain [24]. Recent paper has reported that UBT has antiallergic effects in the contact dermatitis model [25]. Nevertheless, the scientific proof and mechanistic basis for the effect of UBT have almost not been elucidated. Here, we determined anti-inflammatory effects of UBT in vivo and in vitro.

Swelling is a major characteristic of acute inflammation cause by increase vascular permeability [26]. Therefore, induction of edema by carrageenan is a well-established model screening the effects of novel anti-inflammatory drugs [19, 27, 28]. Here, carrageenan successfully induced acute inflammation in the aspect of paw swelling and immunohistochemical analysis in the tissue stained with H&E [29]. Oral administration of UBT significantly decreased carrageenan-increased paw volume and inflammatory cell infiltrations. Moreover, it has been shown that NO and PGE₂ might have important function in development of hyperalgesia in the process of inflammatory response and tissue injury [30–32]. These results demonstrated that UBT attenuates the acute the inflammation in rats.

NO is a significant regulator in the processes of pathophysiological symptoms (e.g., inflammation). A small amount of NO has beneficial functions including regulation of immune mechanism, vasodilation, and platelet inhibition. However, a high level of NO could induce damage to normal cell. LPS is known to activate macrophages to induce proinflammatory mediators, and NO is a hall marker of activation of immune cell in acute inflammation [33, 34]. In this study, we confirmed the effect of UBT on production of NO in LPS-inducible RAW264.7 cells. Treatment of UBT significantly inhibited production of NO and PGE₂, another marker of inflammation. Moreover, UBT markedly blocked the iNOS protein levels, showing that UBT may have the effects on NO production by LPS through suppression of iNOS gene.

Cytokines play a significant role in inflammation disease to activate macrophage [35]. TNF-α was determined as a main inflammation mediator and an initiator of immune response [35]. TNF-α is produced by immune cells and could increase the expression of other cytokines such as ILs [36]. IL-6 is also one of the most important mediators of initiating the synthesis of PGE₂. In this study, we determined the level of cytokines in media of RAW264.7 cells and confirmed the effects of UBT on cytokine level, showing that UBT has an ability of inhibiting acute inflammation in vivo and in vitro.

NF-κB is a transcription factor controlling of the gene expressions involving inflammation, immune responses, and survival [21, 22, 37]. It is well established that drug candidates for the inflammation have inhibitory effects on nitric oxide, eicosanoids, and cytokines by suppressing NF-κB activation [38]. Moreover, it has been shown that the promoters of iNOS and TNF-α include the binding sites for transcription factors, among which NF-κB is known as one of the most important factors for their gene transcription. In fact, activation of NF-κB transcriptionally induces the expression of various inflammatory mediators [39, 40]. The degradation of I-κBα by phosphorylation causes activation and resultantly translocation of NF-κB to nucleus. Our results verify that UBT blocked accumulation of NO and related gene expression through inhibition of I-κBα-NF-κB pathway.

5. Conclusion

In this study, we confirmed anti-inflammatory effects of UBT in vivo and in vitro. We used two approaches to show the effect of UBT: an animal model, a carrageenan-induced acute inflammation, and a cell model, an activated macrophage induced by LPS. In rats, UBT reduced inflammatory responses in carrageenan-induced paw swelling model. In macrophages, UBT has inhibitory effects on NO, PGE₂, and cytokines as well as gene expression of iNOS. More importantly, the suppression of acute inflammation by UBT might result from its inhibition of NF-κB activation by blocking degradation of I-κBα as mediated with inhibition of JNK and p38. The findings here might help to understand the pharmacological effects and mechanism of the UBT and suggest the possibility for the treatment of inflammatory disease as a herbal formula.

Abbreviations

ERK: | Extracellular signal-regulated kinase
ILs: | Interleukins
iNOS: | Inducible nitric oxide synthase
I-κB: | Inhibitory kappa B
JNK: | c-Jun NH₂-terminal kinase
LPS: | Lipopolysaccharide
MAPKs: | Mitogen-activated protein kinases
NF-κB: | Nuclear factor-kappa B
: | Prostaglandin
TNF-α: | Tumor necrosis factor-α.
UBT: | U-bang-haequi tang

Conflict of Interests

The authors declare that they have no competing financial interests.

Authors’ Contribution

Min Hwangbo, Ji Yun Jung, and Sung Hwan Ki are equally contributed to this work.

Acknowledgments

This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea government [MSIP] (no. 2011-0030124). Min Hwangbo would like to thank the Ph.D. Program at DHU for completing the thesis through this work.

References

A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008.

G. Brevetti, G. Giugliano, L. Brevetti, and W. R. Hiatt, “Inflammation in peripheral artery disease,” Circulation, vol. 122, no. 18, pp. 1862–1875, 2010.

S. Hummasti and G. S. Hotamisligil, “Endoplasmic reticulum stress and inflammation in obesity and diabetes,” Circulation Research, vol. 107, no. 5, pp. 579–591, 2010.

B. N. Lambrecht and H. Hammad, “The role of dendritic and epithelial cells as master regulators of allergic airway inflammation,” The Lancet, vol. 376, no. 9743, pp. 835–843, 2010.

E. Christaki, S. M. Opal, J. C. Keith Jr. et al., “Estrogen receptor β agonism increases survival in experimentally induced sepsis and ameliorates the genomic sepsis signature: a pharmacogenomic study,” Journal of Infectious Diseases, vol. 201, no. 8, pp. 1250–1257, 2010.

D. B. Reddy and P. Reddanna, “Chebulagic Acid (CA) attenuates LPS-induced inflammation by suppressing NF-κB and MAPK activation in RAW 264.7 macrophages,” Biochemical and Biophysical Research Communications, vol. 381, no. 1, pp. 112–117, 2009.

P. Datla, M. D. Kalluri, K. Basha et al., “9,10-dihydro-2,5-dimethoxyphenanthrene-1,7-diol, from Eulophia ochreata, inhibits inflammatory signalling mediated by Toll-like receptors,” British Journal of Pharmacology, vol. 160, no. 5, pp. 1158–1170, 2010.

H. W. Jung, C.-H. Yoon, K. M. Park, H. S. Han, and Y.-K. Park, “Hexane fraction of Zingiberis Rhizoma Crudus extract inhibits the production of nitric oxide and proinflammatory cytokines in LPS-stimulated BV2 microglial cells via the NF-kappaB pathway,” Food and Chemical Toxicology, vol. 47, no. 6, pp. 1190–1197, 2009.

Y.-H. Wang, Y.-C. Shen, J.-F. Liao et al., “Anti-inflammatory effects of dimemorfan on inflammatory cells and LPS-induced endotoxin shock in mice,” British Journal of Pharmacology, vol. 154, no. 6, pp. 1327–1338, 2008.

C. C. Corriveau and R. L. Danner, “Endotoxin as a therapeutic target in septic shock,” Infectious Agents and Disease, vol. 2, no. 1, pp. 35–43, 1993.

D. S. Bae, C. Y. Kim, and J. K. Lee, “Anti-inflammatory effects of dehydrogeijerin in LPS-stimulated murine macrophages,” International Immunopharmacology, vol. 14, no. 4, pp. 734–739, 2012.

Y. J. Kim, Y. S. Shin, K. H. Lee, and T. J. Kim, “Anethum graveloens flower extracts inhibited a lipopolysaccharide- induced inflammatory response by blocking iNOS expression and NF-κB activity in macrophage,” Bioscience, Biotechnology, and Biochemistry, vol. 76, no. 6, pp. 1122–1127, 2012.

A. Yoshimura, “Signal transduction of inflammatory cytokines and tumor development,” Cancer Science, vol. 97, no. 6, pp. 439–447, 2006.

A. S. Baldwin, “The NF-kappa B and I kappa B protein: new discoveries and insights,” Annual Review of Immunology, vol. 14, pp. 649–683, 1996.

Y.-C. Oh, W.-K. Cho, G. Y. Im et al., “Anti-inflammatory effect of Lycium Fruit water extract in lipopolysaccharide-stimulated RAW 264.7 macrophage cells,” International Immunopharmacology, vol. 13, no. 2, pp. 181–189, 2012.

S. G. Harris, J. Padilla, L. Koumas, D. Ray, and R. P. Phipps, “Prostaglandins as modulators of immunity,” Trends in Immunology, vol. 23, no. 3, pp. 144–150, 2002.

R. L. C. Handy and P. K. Moore, “A comparison of the effects of L-NAME, 7-NI and L-NIL on caurageenan-induced hindpaw oedema and NOS activity,” British Journal of Pharmacology, vol. 123, no. 6, pp. 1119–1126, 1998.

Y. W. Kim, R. J. Zhao, S. J. Park et al., “Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-κB-dependent iNOS and proinflammatory cytokines production,” British Journal of Pharmacology, vol. 154, no. 1, pp. 165–173, 2008.

L. B. Katz, H. M. Theobald, R. C. Bookstaff, and R. E. Peterson, “Characterization of the enhanced paw edema response to carrageenan and dextran in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 230, no. 3, pp. 670–677, 1984.

S. Z. Hussein, K. Mohd Yusoff, S. Makpol, and Y. A. Mohd Yusof, “Gelam honey attenuates carrageenan-induced rat paw inflammation via NF-κB pathway,” PLoS ONE, vol. 8, no. 8, Article ID e72365, 2013.

S. Ghosh and M. Karin, “Missing pieces in the NF-κB puzzle,” Cell, vol. 109, no. 2, pp. S81–S96, 2002.

G. Bonizzi and M. Karin, “The two NF-κB activation pathways and their role in innate and adaptive immunity,” Trends in Immunology, vol. 25, no. 6, pp. 280–288, 2004.

J. Y. Cha, J. Y. Jung, J. Y. Jung et al., “Inhibitory effects of traditional herbal formula pyungwi-san on inflammatory response in vitro and in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 630198, 19 pages, 2013.

N. Wiseman and F. Ye, A Practical Dictionary of Chinese Medicine, Paradigm Publications, 2nd edition, 1998.

N. H. Kim and K. J. Kim, “Anti-inflammatory effects of WooBangHaeGiTang on the allergic contact dermatitis,” The Journal of Oriental Medicine Ophthalmology & Otolaryngology & Dermatology, vol. 19, pp. 59–70, 2006.

L. C. Ferreira, A. Grabe-Guimarães, C. A. de Paula et al., “Anti-inflammatory and antinociceptive activities of Campomanesia adamantium,” Journal of Ethnopharmacology, vol. 145, no. 1, pp. 100–108, 2013.

M. di Rosa, “Prostaglandins, leucocytes and non steroidal anti inflammatory drugs,” Polish Journal of Pharmacology and Pharmacy, vol. 26, no. 1-2, pp. 25–36, 1974.

J. Garcia Leme, L. Hamamura, M. P. Leite, and M. Rocha e Silva, “Pharmacological analysis of the acute inflammatory process induced in the rat's paw by local injection of carrageenin and by heating,” British Journal of Pharmacology, vol. 48, no. 1, pp. 88–96, 1973.

K. H. Shon, M. J. Jo, W. J. Cho et al., “Bojesodok-eum, an herbal prescription, ameliorates acute inflammation in association with the inhibition of NF-κB mediated nitric oxide and pro-inflammatory cytokines production,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 457370, 9 pages, 2012.

G. Ren, X. Zhao, L. Zhang et al., “Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression,” Journal of Immunology, vol. 184, no. 5, pp. 2321–2328, 2010.

W. N. Durán, J. W. Breslin, and F. A. Sánchez, “The NO cascade, eNOS location, and microvascular permeability,” Cardiovascular Research, vol. 87, no. 2, pp. 254–261, 2010.

M. J. Coffey, S. M. Phare, and M. Peters-Golden, “Induction of inducible nitric oxide synthase by lipopolysaccharide/ interferon gamma and sepsis down-regulates 5-lipoxygenase metabolism in murine alveolar macrophages,” Experimental Lung Research, vol. 30, no. 7, pp. 615–633, 2004.

C. W. Lee, S. C. Kim, T. W. Kwak et al., “Anti-inflammatory effects of Bangpungtongsung-san, a traditional herbal prescription,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 892943, 12 pages, 2012.

Y.-I. Yang, H.-C. Shin, S. H. Kim, W.-Y. Park, K.-T. Lee, and J.-H. Choi, “6,6′-bieckol, isolated from marine alga Ecklonia cava, suppressed LPS-induced nitric oxide and PGE₂ production and inflammatory cytokine expression in macrophages: the inhibition of NFκB,” International Immunopharmacology, vol. 12, no. 3, pp. 510–517, 2012.

F. M. Brennan, R. N. Maini, and M. Feldmann, “Role of pro-inflammatory cytokines in rheumatoid arthritis,” Springer Seminars in Immunopathology, vol. 20, no. 1-2, pp. 133–147, 1998.

D. M. Butler, A. M. Malfait, L. J. Mason, et al., “DBA/1 mice expressing the human TNF-alpha transgene develop a sever, erosive arthritis: characterization of the cytokine cascade and cellular composition,” The Journal of Immunology, vol. 159, pp. 2867–2876, 1997.

M. S. Hayden and S. Ghosh, “Signaling to NF-κB,” Genes and Development, vol. 18, no. 18, pp. 2195–2224, 2004.

N. Mukaida, M. Morita, Y. Ishikawa et al., “Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-κB is target for glucocorticoid-mediated interleukin 8 gene repression,” The Journal of Biological Chemistry, vol. 269, no. 18, pp. 13289–13295, 1994.

Y. Hattori, S. Hattori, and K. Kasai, “Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation,” European Journal of Pharmacology, vol. 481, no. 2-3, pp. 153–158, 2003.

A. B. Carter, K. L. Knudtson, M. M. Monick, and G. W. Hunninghake, “The p38 mitogen-activated protein kinase is required for NF-κB- dependent gene expression. The role of TATA-Binding Protein (TBP),” The Journal of Biological Chemistry, vol. 274, no. 43, pp. 30858–30863, 1999.